Cargando…
Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer
The majority of breast cancers are driven by the female hormone oestrogen via oestrogen receptor (ER) alpha. ER-positive patients are commonly treated with adjuvant endocrine therapy, however, resistance is a common occurrence and aside from ER-status, no unequivocal predictive biomarkers are curren...
Autores principales: | Khan, Sofia, Fagerholm, Rainer, Kadalayil, Latha, Tapper, William, Aittomäki, Kristiina, Liu, Jianjun, Blomqvist, Carl, Eccles, Diana, Nevanlinna, Heli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790536/ https://www.ncbi.nlm.nih.gov/pubmed/29423119 http://dx.doi.org/10.18632/oncotarget.22747 |
Ejemplares similares
-
A Genome Wide Meta-Analysis Study for Identification of Common Variation Associated with Breast Cancer Prognosis
por: Rafiq, Sajjad, et al.
Publicado: (2014) -
Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families
por: Muranen, Taru A., et al.
Publicado: (2016) -
Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
por: Muranen, Taru A, et al.
Publicado: (2011) -
Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women
por: Kadalayil, Latha, et al.
Publicado: (2017) -
Comprehensive analysis of NuMA variation in breast cancer
por: Kilpivaara, Outi, et al.
Publicado: (2008)